Cardiothoracic & vascular anaesthesia

Statin therapy after elective abdominal aortic aneurysm repair improves long-term survival

Br J SurgPublished Retrospective cohort study

Main finding · Long-term survival, postoperative statin use vs no statin use during follow-upResult — go to the resultHazard ratio (long-term survival) 1.43 95% CI 1.34–1.54

Authors' conclusion

In this nationwide propensity score matched cohort study, preoperative statin treatment had no benefit regarding 90-day perioperative survival, but postoperative statin treatment markedly improved long-term survival.

Study context

Population
Patients undergoing elective abdominal aortic aneurysm repair, Swedish nationwide registers, 2006 to 2018three propensity score matched cohorts
Exposure
Statin use vs no statin use; high-intensity vs low-moderate-intensity statin therapy
Outcome
Long-term survival, postoperative statin use vs no statin use during follow-up
Follow-up
Long-term
Methodological detailspropensity score matched, nationwide registers
  • Propensity score matched
  • Nationwide registers

Main finding

As reported in the abstract

Hazard ratio (long-term survival)

1.43

95% CI 1.34–1.54

Postoperative statin users vs Non-users
HR (long-term survival) 1.43 (95% CI 1.34–1.54)

Observational data: associations, not effects.

Further findings

OutcomeHR (long-term survival) (95% CI)
Long-term survival, high-intensity vs low-medium-intensity statin therapy · long-term follow-upNo advantage of high-intensity therapy · propensity score matched cohort1.00 (0.80–1.25)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Statin therapy after elective abdominal aortic aneurysm repair improves long-term survival. Br J Surg. Published 10 January 2024. doi:10.1093/bjs/znad383

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.